Author

Chunyan Wang

Convalife (China)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Organism:bacteria (other)· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:cryo-EM· 1 Research Focus:host-pathogen & immune response· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

David O. Popoola· 1 shared Hao HuangiD· 1 shared Huaxin YuiD· 1 shared Ian J. MolineuxiD· 1 shared Jian YueiD· 1 shared Jinwen HuangiD· 1 shared Jun LiuiD· 1 shared Junfang Pan· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

David O. Popoola

Author profile →

3 papers

Recent·Most cited

Sequential assembly in vivo of the bacteriophage P22 genome translocation channel

Huaxin Yu, Jian Yue, Taehyun Park, Chunyan Wang, Muyuan Chen, Jun Liu, Ian J. Molineux

The paper determines the in vivo structures of P22 infection intermediates and explains how gp10 templates the sequential assembly of three proteins into a trans-envelope channel for genome translocation.

bioRxiv · Sep 9, 2026 · PreprintMicrobiology

Lung-Targeting Interleukin-10 mRNA Lipid Nanoparticles Ameliorate Acute Lung Injury

Yuqin Men, David O. Popoola, Yuqi Song, Zhi Long Cao, Robert Gardner, Rezwana Karim, Chunyan Wang, Nathan R. Tucker, Robert N. Cooney, Qinghe Meng, Yamin Li

This study develops lung-targeted IL-10 mRNA lipid nanoparticles that reduce acute lung injury in a mouse model by attenuating inflammation and tissue damage.

bioRxiv · Jan 23, 2026 · PreprintBioengineering

A Novel Bispecific Antibody CVL006 Superior to AK112 for Dual Targeting of PD-L1 and VEGF in Cancer Therapy

Chunyan Wang, Hao Huang, Zeng Song, Zhongyuan Li, Jinwen Huang, Liang Cao, Ziai Wu, Junfang Pan, Xiaobing Chen, Xiaokun Shen

This paper develops a bispecific antibody CVL006 that targets PD-L1 and VEGF, showing superior antitumor efficacy compared to existing therapies in preclinical models.

Antibody Therapeutics · May 21, 2025Peer-reviewedPharmacology & Toxicology